9 Pharma segment saw healthy 69% yoy jump in sales with 510bps expansion in EBIT marginto17.1%.Expects+20%growthinFY17ledbyrecentdebottlenecking. Key highlights: Reported inline operating performance with 3% sales growth and 210bps...